The effect of sevoflurane versus propofol anesthesia on troponin I after congenital heart surgery, a randomized clinical trial


1 Yazd Cardiovascular Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

2 Department of Anesthesiology, Faculty Member of Shahid Sadoughi Medical University of Yazd (Anesthesia and Operation Room Group), Yazd, Iran


Background : The ischemic preconditioning phenomenon can save myocardium against move severe ischemic damages and reduce infarction size and furthermore a heart rhythm disturbance. In this study we examine relationship between troponin I (as a structural myocardial protein) level and anesthetic agents in the children.
Materials and Methods: In this study 84 children under 12 years age before cardiac surgery were divided randomly into two groups of 42 each. For anesthetic maintenance sevoflurane with dose of 0.5-1 MAC was used in Group 1 and 100-150 mg/kg/min of intravenous propofol in Group 2 for maintenance of anesthesia. Troponin I level was assessed 2 before and 1 hour after anesthetic induction. Outcome measures included the serum cardiac troponin I level in children before and after surgery in two study groups.
Results: There was no significant difference between two groups in indices and both groups were homogenous in this point of view. The troponin I level after surgery was significantly increased in two groups. In the sevoflurane group it was 0.04 ± 0.12 to 0.05 ± 0.09 ng/ml (P value = 0.003) and the propofol group was 0.12 ± 0.26 to 0.19 ± 0.38 ng/ml (P value = 0.001).
Conclusions: In this study two Anesthetic regimens were compared to assess the mean troponin I level before and after pediatric closed heart surgery, and it was shown that mean troponin level before and after surgery in the sevoflurane group was less than the propofol group. But this result was not statistically significant. These results indicate that although more protective effects of sevoflurane on myocardial injuries during pediatric cardiac surgery is predominant but this effect has no significant difference in the propofol group.


Romano-Zelekha O, Hirsh R, Blieden L, Green M, Shohat T. The risk forcongenital heart defects in offspring of individuals with congenital heartdefects. Clin Genet 2001;59:325-9.  Back to cited text no. 1
Warnes CA, Liberthson R, Danielson GK, Dore A, Harris L, Hoffman JI, et al. Task force 1: The changing profile of congenital heart disease in adult life. J Am Coll Cardiol 2001;37:1170-5.  Back to cited text no. 2
Frässdorf J, De Hert S, Schlack W. Anaesthesia and myocardial ischaemia/reperfusion injury. Br J Anaesth 2009;103:89-98.  Back to cited text no. 3
Tanaka K, Ludwig LM, Krolikowski JG, Alcindor D, Pratt PF, Kersten JR, et al. Isoflurane produces delayed preconditioning against myocardial ischemia and reperfusion injury: Role of cyclooxygenase-2. Anesthesiology 2004;100:525-31.  Back to cited text no. 4
Hemmerling T, Olivier JF, Le N, Prieto I, Bracco D. Myocardial protection byisoflurane vs. sevoflurane in ultra-fast-track anaesthesia for off-pumpaortocoronary bypass grafting. Eur J Anaesthesiol 2008;25:230-6.  Back to cited text no. 5
Bray RJ. Fatal myocardial failure associated with a propofol infusion in achild. Anaesthesia 1995;50:94.  Back to cited text no. 6
Diao S, Ni J, Shi X, Liu P, Xia W. Mechanisms of action of general anesthetics. Front Biosci (Landmark Ed) 2014;19:747-57.  Back to cited text no. 7
Zvara DA, Bryant AJ, Deal DD, DeMarco MP, Campos KM, Mansfield CM, et al. Anesthetic preconditioning with sevoflurane does not protect the spinal cord after an ischemic-reperfusion injury in the rat. Anesth Analg 2006;102:1341-7.  Back to cited text no. 8
Garcia C, Julier K, Bestmann L, Zollinger A, von Segesser LK, Pasch T, et al. Preconditioning with sevoflurane decreases PECAM-1 expression and improves one-year cardiovascular outcome in coronary artery bypass graft surgery. Br J Anaesth 2005;94:159-65.  Back to cited text no. 9
Malagon I, Hogenbirk K, van Pelt J, Hazekamp MG, Bovill JG. Effect of three different anaesthetic agents on the postoperative production of cardiac troponin T in paediatric cardiac surgery. Br J Anaesth 2005;94:805-9.  Back to cited text no. 10
Thygesen K, Mair J, Katus H, Plebani M, Venge P, Collinson P, et al.; Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care. Recommendations for the use of cardiac troponin measurement in acutecardiac care. Eur Heart J 2010;31:2197-204.  Back to cited text no. 11
Imantalab V, SeddighiNejad A, Mir Mansouri A, SadeghiMeibodi A, Haghighi M, Dadkhah H, et al. A comparative study of cardioprotective effect of three anesthetic agents by measuring serum level of troponin-T after coronary artery bypass grafting. Int Cardiovasc Res J 2012;6:70-4.  Back to cited text no. 12
Pierpont GL, McFalls EO. Interpreting troponin elevations: Do we need multiple diagnoses? Eur Heart J 2009;30:135-8.  Back to cited text no. 13
Flier S, Post J, Concepcion AN, Kappen TH, Kalkman CJ, Buhre WF. Influence of propofol-opioid vsisoflurane-opioid anaesthesia on postoperative troponin release in patients undergoing coronary artery bypass grafting. Br J Anaesth 2010;105:122-30.  Back to cited text no. 14
Xia Z, Huang Z, Ansley DM. Large-dose propofol during cardiopulmonary bypass decreases biochemical markers of myocardial injury in coronary surgery patients: A comparison with isoflurane. Anesth Analg 2006;103:527-32.  Back to cited text no. 15